Design
Review
Authors
Loading...
MR blockade may benefit resistant hypertension with metabolic features; leaves open need for outcome trials.
Key points are not available for this paper at this time.
James R. Sowers (2009) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: